Administrative Core
Administrative Core
批准号:
10621826
负责人:
THOMAS M WISNIEWSKI
金额:
$12.96万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-06-01 至 2025-05-31
关键词:
AccountabilityAdvisory CommitteesAgreementAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAlzheimer&aposs disease pathologyAlzheimer&aposs disease related dementiaAmyloidAmyloid beta-ProteinAnimal ModelApolipoprotein EApolipoproteinsAutomobile DrivingBioinformaticsBiologicalBiological MarkersCaregiversChargeClinicCognitiveCollaborationsCommunitiesDataData AnalysesDevelopmentDisciplineDiseaseDisputesEducationEnsureEventExperimental DesignsFosteringFutureGoalsGrantHealthHuman ResourcesImmunologyInstitutionInterdisciplinary StudyMethodologyMethodsMolecular ConformationNeurologyPathogenesisPathway interactionsPatientsPharmaceutical ChemistryPlayPoliciesPositioning AttributeProgram Research Project GrantsProgress ReportsProtein ConformationProtein IsoformsProteomicsQuality ControlRecording of previous eventsResearchResearch PersonnelResearch Project GrantsResearch ProposalsResourcesRoleScientistSeriesStructureTherapeuticTranslatingUnited States National Institutes of Healthchemical resourcedata managementdata sharinghuman tissueimmunoregulationknowledge basemeetingsmouse modelmultidisciplinaryneuroimagingneuropathologynovel strategiesoperationpre-clinicalprogramsresponseresponsible research conductsuccesssynergismtau aggregationtherapeutic development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
CORE A- SUMMARY/ABSTRACT
Our ultimate goal of this program grant is to gain a better understanding of the heterogeneous pathogenesis of
AD and how it is influenced by apolipoprotein (apo) E isotypes, using human tissue, with correlations to
findings in various AD models, using proteomic and other methods which we have recently developed. In
particular we are focusing on the differential role apolipoprotein E (apoE) isoforms play in: 1) AD plaque and
vessel amyloid development (Project 1); 2) therapeutic approaches that target the Aβ/apoE interaction (Project
2); 3) responses to therapeutic immunomodulation targeting abnormal conformation (Project 3). The
Administrative Core (Core A) is charged with ensuring the success of this research proposal. The Aims are:
Aim 1. Provide administrative structure and fiscal oversight for the program project grant.
Aim 2. Organize regular meetings of the Executive Committee (EC) composed of Project and Core Leaders
and other key personnel to assist in scientific administration and to facilitate integration and continuing
progress on research aims.
Aim 3. Coordinate with the bioinformatics/statistical/data management Core D to ensure optimal data
utilization and scientific rigor for the Program Project.
Aim 4. Interact closely with the External Advisory Committee and Internal Advisory Board, and conduct regular
meetings of both. The External Advisory Committee and Internal Advisory Board will provide scientific advice
and guidance for all research projects.
Aim 5. Report progress to NIH and ensure compliance with the NIH Public Access policy.
Aim 6. Promote education on AD and related disorders, and facilitate P01 scientists’ participation in education
to researchers, clinicians and patients/caregivers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Alzheimer's Disease Research Center
-
批准号:10439576
-
项目类别:
-
资助金额:$321.46万
-
财政年份:2020
-
负责人:THOMAS M WISNIEWSKI
-
依托单位:
Alzheimer's Disease Research Center
-
批准号:10158691
-
项目类别:
-
资助金额:$42.1万
-
财政年份:2020
-
负责人:THOMAS M WISNIEWSKI
-
依托单位:
Biomarker Core
-
批准号:10643943
-
项目类别:
-
资助金额:$24.25万
-
财政年份:2020
-
负责人:THOMAS M WISNIEWSKI
-
依托单位:
Alzheimer's Disease Research Center
-
批准号:9921985
-
项目类别:
-
资助金额:$331.89万
-
财政年份:2020
-
负责人:THOMAS M WISNIEWSKI
-
依托单位:
Novel Approaches to Understand the Pathogenesis and Treat Alzheimer's Disease
-
批准号:10621825
-
项目类别:
-
资助金额:$235.85万
-
财政年份:2020
-
负责人:THOMAS M WISNIEWSKI
-
依托单位:
Neuropathology Core
-
批准号:10643933
-
项目类别:
-
资助金额:$23.17万
-
财政年份:2020
-
负责人:THOMAS M WISNIEWSKI
-
依托单位:
Alzheimer's Disease Research Center
-
批准号:10828230
-
项目类别:
-
资助金额:$15.97万
-
财政年份:2020
-
负责人:THOMAS M WISNIEWSKI
-
依托单位:
Novel Approaches to Understand the Pathogenesis and Treat Alzheimer's Disease
-
批准号:10428579
-
项目类别:
-
资助金额:$239.89万
-
财政年份:2020
-
负责人:THOMAS M WISNIEWSKI
-
依托单位:
Alzheimer's Disease Research Center
-
批准号:10165858
-
项目类别:
-
资助金额:$34.89万
-
财政年份:2020
-
负责人:THOMAS M WISNIEWSKI
-
依托单位:
Blocking the binding of Aβ and apoE as a novel therapeutic approach for AD
-
批准号:10428585
-
项目类别:
-
资助金额:$62.04万
-
财政年份:2020
-
负责人:THOMAS M WISNIEWSKI
-
依托单位:
Biomarker Core
-
批准号:10439584
-
项目类别:
-
资助金额:$32.04万
-
财政年份:2020
-
负责人:THOMAS M WISNIEWSKI
-
依托单位:
Alzheimer's Disease Research Center
-
批准号:10643919
-
项目类别:
-
资助金额:$317.13万
-
财政年份:2020
-
负责人:THOMAS M WISNIEWSKI
-
依托单位:
Administrative Core
-
批准号:10428580
-
项目类别:
-
资助金额:$12.62万
-
财政年份:2020
-
负责人:THOMAS M WISNIEWSKI
-
依托单位:
Administrative Core
-
批准号:10439577
-
项目类别:
-
资助金额:$52.49万
-
财政年份:2020
-
负责人:THOMAS M WISNIEWSKI
-
依托单位:
Neuropathology Core
-
批准号:10439581
-
项目类别:
-
资助金额:$27.24万
-
财政年份:2020
-
负责人:THOMAS M WISNIEWSKI
-
依托单位:
Administrative Core
-
批准号:10643920
-
项目类别:
-
资助金额:$57.47万
-
财政年份:2020
-
负责人:THOMAS M WISNIEWSKI
-
依托单位:
Alzheimer's Disease Research Center
-
批准号:10828231
-
项目类别:
-
资助金额:$15.97万
-
财政年份:2020
-
负责人:THOMAS M WISNIEWSKI
-
依托单位:
Alzheimer's Disease Research Center- Supplement 3.2- Mark Bernard 2022
-
批准号:10610048
-
项目类别:
-
资助金额:$13.31万
-
财政年份:2020
-
负责人:THOMAS M WISNIEWSKI
-
依托单位:
Blocking the binding of Aβ and apoE as a novel therapeutic approach for AD
-
批准号:10621848
-
项目类别:
-
资助金额:$51.45万
-
财政年份:2020
-
负责人:THOMAS M WISNIEWSKI
-
依托单位:
Alzheimer's Disease Research Center- Supplement 3.1- Anthony Briggs 2022
-
批准号:10610057
-
项目类别:
-
资助金额:$11.98万
-
财政年份:2020
-
负责人:THOMAS M WISNIEWSKI
-
依托单位:
海外基金